Heron Therapeutics (HRTX) Operating Leases (2019 - 2026)
Heron Therapeutics' (HRTX) quarterly Operating Leases came in at $780000.0 in Q3 2025, up 49.43% YoY from $522000.0 in Q3 2024, and down 49.32% on a QoQ basis from $1.5 million in Q2 2025.
Heron Therapeutics (HRTX) Operating Leases (2019 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 7 years of Operating Leases data on file, last reported at $780000.0 in Q3 2025.
- Quarterly Operating Leases rose 49.43% year-over-year to $780000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $780000.0 (up 49.43% YoY) and the FY2023 annual result came in at $2.8 million, down 49.08% from the prior year.
- Operating Leases slipped to $780000.0 in Q3 2025, from $1.5 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $13.8 million in Q1 2021 to a low of $522000.0 in Q3 2024.
- A 5-year average of $5.5 million and a median of $4.8 million in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases tumbled 85.24% — and 2025, when it soared 49.43%.
- Tracing HRTX's Operating Leases over 5 years: stood at $8.0 million in 2021, then sank by 31.23% to $5.5 million in 2022, then slumped by 49.08% to $2.8 million in 2023, then tumbled by 81.36% to $522000.0 in 2024, then soared by 49.43% to $780000.0 in 2025.
- The last three Operating Leases figures came in at $780000.0 (Q3 2025), $1.5 million (Q2 2025), and $522000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - |
| 10 | Heron Therapeutics | 60.91 Mn | 18.24 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50 Mn |
| Sep 30, 2025 | 780,000.00 |
| Jun 30, 2025 | 1.54 Mn |
| Sep 30, 2024 | 522,000.00 |
| Jun 30, 2024 | 1.29 Mn |
| Mar 31, 2024 | 2.05 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 3.54 Mn |
| Jun 30, 2023 | 4.16 Mn |
| Mar 31, 2023 | 4.83 Mn |
| Dec 31, 2022 | 5.50 Mn |
| Sep 30, 2022 | 6.15 Mn |
| Jun 30, 2022 | 6.78 Mn |
| Mar 31, 2022 | 7.39 Mn |
| Dec 31, 2021 | 8.00 Mn |
| Sep 30, 2021 | 12.22 Mn |
| Jun 30, 2021 | 13.01 Mn |
| Mar 31, 2021 | 13.79 Mn |
| Dec 31, 2020 | 14.56 Mn |
| Sep 30, 2020 | 15.30 Mn |